C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors
Position in ABT — Abbott Laboratories
CIK 1965756
Westlake, OH
Position in ABT
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,786,398
-$223,161 QoQ
Shares Held
19,687
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#1,157
of 2,958 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors holds $1,990,066 across 2 Medical Devices names. ABT ranks #1 (89.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
19,687 | $1,786,398 | |
| 2 | BSX |
Boston Scientific Corp
|
4,772 | $203,668 |
All Filings in ABT
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,786,398 | 19,687 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $2,009,559 | 19,573 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $2,481,117 | 19,803 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,805,909 | 20,949 | Shares | Sole | 2025-10-21 | |
| 2025-03-31 | $2,728,875 | 20,572 | Shares | Sole | 2025-05-12 | |
| 2024-09-30 | $2,377,336 | 20,852 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $588,650 | 5,665 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,331,848 | 20,516 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,019,784 | 18,350 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,762,476 | 18,198 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,917,988 | 17,593 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $1,752,505 | 17,307 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $1,887,948 | 17,196 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||